Table 3.
Lymphoma subtype among 172 adult NHL cases
| Precursor lymphoid neoplasms | 8 (4.7%) |
| B lymphoblastic leukaemia/lymphoma | 1 (0.6%) |
| T lymphoblastic leukaemia/lymphoma | 4 (2.4%) |
| Blastic leukaemia/lymphoma, not otherwise specified | 3 (1.8%) |
| Mature B-cell neoplasms | 157 (91.3%) |
| Chronic lymphocytic leukaemia / small lymphocytic lymphoma | 16 (9.4%) |
| Lymphoplasmacytic lymphoma | 1 (0.6%) |
| Plasmacytoma | 5 (3%) |
| Extranodal marginal zone lymphoma of MALT type | 2 (1.2%) |
| Nodal marginal zone lymphoma | 4 (2.4%) |
| Mantle cell lymphoma | 1 (0.6%) |
| Follicular lymphoma | 5 (3%) |
| Primary cutaneous follicular lymphoma | 1 (0.6%) |
| Diffuse large B-cell lymphoma (DLBCL) | 95 (55%) |
| Plasmablastic lymphoma | 6 (3.6%) |
| Burkitt lymphoma (BL) | 15 (9%) |
| B-cell lymphoma, unclassifiable with features intermediate between DLBCL & BL | 5 (3%) |
| B-cell lymphoma, unclassifiable with features intermediate between DLBCL & classical Hodgkin lymphoma | 1 (0.6%) |
| Mature T-cell & NK cell neoplasms | 5 (3%) |
| Extranodal NK/T cell lymphoma, nasal type | 1 (0.6%) |
| Peripheral T-cell lymphoma, not otherwise specified | 3 (1.8%) |
| Primary cutaneous anaplastic large cell lymphoma | 1 (0.6%) |
| NHL, not further classifiable due to technical reasons | 2 |
DLBCL, diffuse large B-cell lymphoma ; BL, Burkitt lymphoma ; MALT, mucosa-associated lymphoid tissue